Sandra Beaver
Vermögen: 335 229 $ am 31.05.2026
Vermögen: 335 229 $ am 31.05.2026
Sandra Beaver is currently an Independent Director at Tandem Diabetes Care, Inc. and Chief Financial Officer at Lyra Health, Inc., both positions starting in 2025.
Former roles include Chief Financial Officer at Evolus, Inc. from 2022 to 2025 and Senior Vice President-Finance at Experian Plc from 2019 to 2022.
Education includes undergraduate studies at the University of Massachusetts.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EVOLUS, INC. 0.08% | 17.04.2026 | 51’102 ( 0.08% ) | 335 229 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Direktor/Vorstandsmitglied | 07.11.2025 |
Lyra Health, Inc.
Lyra Health, Inc. Investment ManagersFinance Provides workforce mental health benefits services | Finanzdirektor/CFO | 01.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| EVOLUS, INC. | Finanzdirektor/CFO | 13.06.2025 |
| EXPERIAN PLC | Corporate Officer/Principal | 01.09.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Experian Plc
Experian Plc Miscellaneous Commercial ServicesCommercial Services Provides decision analytics, marketing services, consumer services and credit services | Commercial Services |
Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of diabetes | Health Technology |
Evolus, Inc.
Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Health, Inc.
Lyra Health, Inc. Investment ManagersFinance Provides workforce mental health benefits services | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen